Jordi Heijman

Assistant Professor

Dr Jordi Heijman studied Knowledge Engineering and obtained his PhD cum laude (a distinction awarded to only 5% of PhDs in the Netherlands) in April 2012, for his work on a joint project between the Dept. of Cardiology and the Dept. of Data Science and Knowledge Engineering at Maastricht University. As part of his PhD, he spent 1.5 years at the renowned Cardiac Bioelectricity and Arrhythmia Center, Washington University in St. Louis, USA under the supervision of Prof. Yoram Rudy. After completing his PhD, he worked as a postdoctoral fellow at the Medical Faculty Mannheim, Heidelberg University, and the Institute of Pharmacology, University Duisburg-Essen (director: Prof. Dobromir Dobrev). In April 2015, he was recruited back to Maastricht University as an Assistant Professor at the Department of Cardiology to strengthen the translational axis between CARIM and the Maastricht UMC+ Heart+Vascular Center for their strategic focus area ‘cardiac arrhythmias’.

Jordi’s research combines experimental and computational methods to investigate the mechanisms of cardiac arrhythmias. His work is funded by prestigious grants (NWO Veni, Dutch Heart Foundation/CVON Predict Young Talent Program). He has published >55 peer-reviewed articles, the majority as (shared-)first author, many in high-impact journals, covering various topics related to heart rhythm disorders. These articles have been cited >1650 times, and emphasise the need for interdisciplinary research to advance the diagnosis and treatment of cardiac arrhythmias. His expertise is recognised as invited speaker for numerous international conferences, including the EHRA, ESC, and HRS meetings, and as referee for scientific journals and grant applications.

Furthermore, he serves on various committees, including the nucleus of the ESC Working Group on Cardiac Cellular Electrophysiology, the nucleus of the Working Group Cellular Electrophysiology of the German Cardiac Society, and the Strategic Board of CARIM. He is an associate editor for International Journal of Cardiology: Heart & Vasculature and in 2018 was Co-Chair of the 45thComputing in Cardiology conference. His work has received attention from several general media in response to a nomination for the popular science magazine NewScientist’s top 25 of young scientific talent 2016.

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht

  • 2021
    • Sutanto, H., Dobrev, D., & Heijman, J. (2021). Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias. International journal of molecular sciences, 22(16), [8994]. https://doi.org/10.3390/ijms22168994
    • Nedios, S., Lindemann, F., Heijman, J., Crijns, H. J. G. M., Bollmann, A., & Hindricks, G. (2021). Atrial remodeling and atrial fibrillation recurrence after catheter ablation: Past, present, and future developments. Herz, 46(4), 312-317. https://doi.org/10.1007/s00059-021-05050-1
    • Sultan, A., Wormann, J., Luker, J., van der Bruck, J. H., Plenge, T., Rudolph, V., Klinke, A., Heijman, J., Mollenhauer, M., Ravekes, T., Baldus, S., & Steven, D. (2021). Significance of myeloperoxidase plasma levels as a predictor for cardiac resynchronization therapy response. Clinical research in cardiology, 110(8), 1173-1180. https://doi.org/10.1007/s00392-020-01690-1
    • Heijman, J., Sutanto, H., Crijns, H. J. G. M., Nattel, S., & Trayanova, N. A. (2021). Computational models of atrial fibrillation: achievements, challenges and perspectives for improving clinical care. Cardiovascular Research, 117(7), 1682-1699. https://doi.org/10.1093/cvr/cvab138
    • Nattel, S., Sager, P. T., Huser, J., Heijman, J., & Dobrev, D. (2021). Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. Cardiovascular Research, 117(7), 1616-1631. https://doi.org/10.1093/cvr/cvab093
    • Wiedmann, F., Beyersdorf, C., Zhou, X-B., Kraft, M., Paasche, A., Jávorszky, N., Rinné, S., Sutanto, H., Büscher, A., Foerster, K. I., Blank, A., El-Battrawy, I., Li, X., Lang, S., Tochtermann, U., Kremer, J., Arif, R., Karck, M., Decher, N., ... Schmidt, C. (2021). Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy. Cardiovascular Research. https://doi.org/10.1093/cvr/cvab177
    • Wagner, M., Sadek, M. S., Dybkova, N., Mason, F. E., Klehr, J., Firneburg, R., Cachorro, E., Richter, K., Klapproth, E., Kuenzel, S. R., Lorenz, K., Heijman, J., Dobrev, D., El-Armouche, A., Sossalla, S., & Kaemmerer, S. (2021). Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression. International journal of molecular sciences, 22(9), [4816]. https://doi.org/10.3390/ijms22094816
    • Aguilar, M., Heijman, J., Dobrev, D., & Nattel, S. (2021). One Ring to Rule Them All: Continuous Monitoring of Patients With Secondary Atrial Fibrillation Points to a Unifying Underlying Mechanism. Canadian Journal of Cardiology, 37(5), 686-689. https://doi.org/10.1016/j.cjca.2021.01.018
    • Xenakis, M. N., Kapetis, D., Yang, Y., Gerrits, M. M., Heijman, J., Waxman, S. G., Lauria, G., Faber, C. G., Westra, R. L., Lindsey, P. J., & Smeets, H. J. (2021). Hydropathicity-based prediction of pain-causing NaV1.7 variants. BMC Bioinformatics, 22(1), [212]. https://doi.org/10.1186/s12859-021-04119-2
    • Vagos, M. R., Arevalo, H., Heijman, J., Schotten, U., & Sundnes, J. (2021). A Computational Study of the Effects of Tachycardia-Induced Remodeling on Calcium Wave Propagation in Rabbit Atrial Myocytes. Frontiers in physiology, 12, [651428]. https://doi.org/10.3389/fphys.2021.651428